Anthony White, MD
Cardiovascular Disease · Jonesboro, ARNPI 1548239585
Payments from drug & device makers
Across 490 payments — averaging $47.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$16K
- Medtronic$1K
- Novartis$886
- Pfizer$833
- Amgen$639
- Boehringer Ingelheim$475
- plus $3K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 33 | $16,333 |
| Medtronic(2 entities) | 106 | $1,188 |
| Novartis | 67 | $886 |
| Pfizer | 57 | $833 |
| Amgen | 48 | $639 |
| Boehringer Ingelheim | 29 | $475 |
| Johnson & Johnson | 27 | $382 |
| Merck | 26 | $359 |
| AstraZeneca | 12 | $244 |
| Sanofi-aventis U.S. LLC | 12 | $230 |
| Novo Nordisk | 9 | $191 |
| Endologix LLC | 4 | $186 |
| Edwards Lifesciences | 2 | $172 |
| W. L. Gore & Associates, Inc. | 3 | $163 |
| E.r. Squibb & Sons, L.L.C. | 9 | $136 |
| Cvrx, Inc. | 4 | $86 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $85 |
| Lexicon Pharmaceuticals, Inc. | 5 | $77 |
| Inspire Medical Systems, Inc. | 2 | $62 |
| Cordis US CORP. | 2 | $59 |
| Biosense Webster, Inc. | 3 | $58 |
| Bayer | 2 | $50 |
| Esperion Therapeutics, Inc. | 3 | $45 |
| Alnylam Pharmaceuticals Inc. | 3 | $45 |
| Boston Scientific | 2 | $42 |
| Biotronik Inc. | 2 | $32 |
| Shockwave Medical, Inc | 2 | $31 |
| Scpharmaceuticals Inc. | 1 | $26 |
| Abiomed | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Akcea Therapeutics, Inc. | 1 | $21 |
| Chiesi USA, Inc. | 1 | $19 |
| GE HealthCare | 1 | $18 |
| Terumo Medical Corporation | 1 | $15 |
| Atricure, Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
| Elutia, Inc. | 1 | $10 |
| Cardiovascular Systems Inc. | 1 | $4 |
How this compares
$23,271 in reported general payments places this provider in the 80th percentile of 130 cardiovascular disease providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Jonesboro
- Maximiliano ArroyoJonesboro$553K
- Barry TedderJonesboro$178K
- Dharmendra PatelJonesboro$171K
- Michael IsaacsonJonesboro$131K
- Nephertiti EfeovbokhanJonesboro$15K
- Matthew HausteinJonesboro$8K
- Jaime ChavezJonesboro$7K
- Mahesh AradhyaJonesboro$5K
- Ian CawichLittle Rock$1.1M
- Christian Assad KottnerLittle Rock$670K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.